Manojna Konda

Assistant Professor

UAMS

Also affiliated: Jones Institute (2020); Winthrop Rockefeller Foundation (2020–2022); John L. McClellan Memorial Veterans Hospital (2020); Tohoku Medical and Pharmaceutical University (1985)

Faculty Researcher

College of Medicine Administration

6 h-index 47 pubs 132 cited

Research Areas

Biomedical Subjects

Links

ORCID Research Group UAMS TRI Profile

OverviewAI-generated summary

Manojna Konda's research focuses on the epidemiology and outcomes of various hematologic and oncologic conditions. She has investigated the incidence, patient characteristics, and survival outcomes associated with Heavy Chain Disease in the United States and the epidemiology of Aggressive NK-Cell Leukemia in the U.S. using SEER population data. Konda has also explored treatment strategies for multiple myeloma, including tandem autologous stem cell transplantation for patients with persistent minimal residual disease. Her work extends to understanding risk factors and subtypes of ischemic strokes in young adults. Konda has co-authored publications on cancer screening and prevention, examining sex and gender evidence in lung, breast, and colorectal cancers, and has contributed to research on novel therapeutic approaches for endocrine-resistant breast cancer.

Metrics

h-index: 6
Publications: 47
Citations: 132

Selected Publications

Cancer screening and prevention: Sex and gender evidence in lung, breast, and colorectal cancer (2026)

Elsevier eBooks DOI OpenAlex
B-lymphoblastic leukemia/lymphoma with MYC and BCL2 gene rearrangements shows evidence for clonal evolution and mitotic recombination (2023)

Journal of Hematopathology DOI OpenAlex
Geographical distribution of prostate cancer clinical trials across the United States. (2022)

Journal of Clinical Oncology DOI OpenAlex
Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma (2022)

American Journal of Hematology 6 citations DOI OpenAlex
List of Contributors (2021)

Elsevier eBooks DOI OpenAlex
Epidemiology of Aggressive NK-Cell Leukemia in the United States: A SEER Population-Based Study (2021)

Blood 4 citations DOI OpenAlex
Clinical-Laboratory- Genetic Profile and Outcomes of Patients with Atypical Hemolytic Uremic Syndrome and Restrictive Use of Eculizumab: A Single Center Experience and a Brief Review (2021)

Blood DOI OpenAlex
Heavy Chain Disease in the United States: Analysis of Incidence, Patient Characteristics and Survival Outcomes (2021)

Blood 2 citations DOI OpenAlex
Acquired Amegakaryocytic Thrombocytopenia Misdiagnosed as Immune Thrombocytopenia: A Case Report (2020)

The Permanente Journal 12 citations DOI OpenAlex
Treatment Strategies and Outcomes for Patients with Peripheral T-Cell Lymphoma and Its Subtypes (2020)

Blood DOI OpenAlex
C-reactive protein (CRP) as a predictive biomarker in lung cancer patients receiving immune checkpoint inhibitors (ICI). (2020)

Journal of Clinical Oncology 4 citations DOI OpenAlex
Characteristics and factors affecting mortality of patients admitted for chemotherapy in the United States during the year 2017. (2020)

Journal of Clinical Oncology DOI OpenAlex
Gender variation in clinical activity and Medicare payments among medical oncologists and hematologists. (2020)

Journal of Clinical Oncology DOI OpenAlex
Cardiotoxicity and heart failure in patients receiving chemotherapy: A nationwide analysis. (2020)

Journal of Clinical Oncology 1 citation DOI OpenAlex
Tumor-associated antigens and their antibodies in the screening, diagnosis, and monitoring of esophageal cancers (2020)

European Journal of Gastroenterology & Hepatology 10 citations DOI OpenAlex